Latest filing published 26 Jun 2026 for Krystal Biotech, Inc..
Insider track record
No signal scores available.
John Charles Thomas: trading record in brief
John Charles Thomas is a declared insider of Krystal Biotech, Inc., with filings sourced from SEC (Form 4). We count 2 filings, every one of them for a trade on 25 June 2026.
No open-market purchase appears, only 1 sale worth €306k. Outside the open market, there are 1 option exercise.
On 26 June 2026 came the latest disclosure, an open-market sale for €306k in Krystal Biotech, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John Charles Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 sharesCommon StockSEC:0002114900-26-000009:0
1 of 1 declaration
